ID   ST38L_HUMAN             Reviewed;         464 AA.
AC   Q9Y2H1; A8K4U0; Q8TBX7;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 3.
DT   05-OCT-2010, entry version 89.
DE   RecName: Full=Serine/threonine-protein kinase 38-like;
DE            EC=2.7.11.1;
DE   AltName: Full=NDR2 protein kinase;
DE   AltName: Full=Nuclear Dbf2-related kinase 2;
GN   Name=STK38L; Synonyms=KIAA0965, NDR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, INTERACTION WITH S100, PHOSPHORYLATION AT THR-75; SER-282
RP   AND THR-442, AND MUTAGENESIS OF THR-75; LYS-119; SER-282 AND THR-442.
RC   TISSUE=Brain;
RX   PubMed=15037617; DOI=10.1074/jbc.M402472200;
RA   Stegert M.R., Tamaskovic R., Bichsel S.J., Hergovich A.,
RA   Hemmings B.A.;
RT   "Regulation of NDR2 protein kinase by multi-site phosphorylation and
RT   the S100B calcium-binding protein.";
RL   J. Biol. Chem. 279:23806-23812(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=99246063; PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-18; 26-42; 48-64; 73-79; 83-98; 123-161;
RP   213-224; 229-240; 249-266; 340-392 AND 433-460, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, and Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N., Calvo F., Kolch W.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ENZYME REGULATION,
RP   AND INTERACTION WITH MOB1 AND MOB2.
RX   PubMed=15067004; DOI=10.1074/jbc.M401999200;
RA   Devroe E., Erdjument-Bromage H., Tempst P., Silver P.A.;
RT   "Human Mob proteins regulate the NDR1 and NDR2 serine-threonine
RT   kinases.";
RL   J. Biol. Chem. 279:24444-24451(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-99.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the regulation of structural processes in
CC       differentiating and mature neuronal cells (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by binding of S100B which releases
CC       autoinhibitory N-lobe interactions, enabling ATP to bind and the
CC       autophosphorylation of Ser-282. Thr-442 then undergoes calcium-
CC       dependent phosphorylation by an upstream kinase. Interactions
CC       between phosphorylated Thr-442 and the N-lobe promote additional
CC       structural changes that complete the activation of the kinase.
CC       Autoinhibition is also released by the binding of MOB1/MOBKL1A and
CC       MOB2/HCCA2 to the N-terminal of STK38L.
CC   -!- SUBUNIT: Homodimeric S100B binds two molecules of STK38L (By
CC       similarity). Interacts with MOB1 and MOB2.
CC   -!- INTERACTION:
CC       Q15323:KRT31; NbExp=1; IntAct=EBI-991501, EBI-948001;
CC       Q9H8S9:MOBKL1B; NbExp=2; IntAct=EBI-991501, EBI-748229;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton.
CC       Note=Associated with the actin cytoskeleton.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest levels
CC       observed in the thymus.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023182; BAA76809.2; -; mRNA.
DR   EMBL; AK291055; BAF83744.1; -; mRNA.
DR   EMBL; CH471094; EAW96549.1; -; Genomic_DNA.
DR   EMBL; BC028603; AAH28603.1; -; mRNA.
DR   IPI; IPI00237011; -.
DR   RefSeq; NP_055815.1; -.
DR   UniGene; Hs.184523; -.
DR   ProteinModelPortal; Q9Y2H1; -.
DR   SMR; Q9Y2H1; 70-447.
DR   IntAct; Q9Y2H1; 4.
DR   MINT; MINT-1631355; -.
DR   STRING; Q9Y2H1; -.
DR   PhosphoSite; Q9Y2H1; -.
DR   PeptideAtlas; Q9Y2H1; -.
DR   PRIDE; Q9Y2H1; -.
DR   Ensembl; ENST00000389032; ENSP00000373684; ENSG00000211455.
DR   GeneID; 23012; -.
DR   KEGG; hsa:23012; -.
DR   UCSC; uc001rhr.1; human.
DR   CTD; 23012; -.
DR   GeneCards; GC12P027297; -.
DR   H-InvDB; HIX0010505; -.
DR   HGNC; HGNC:17848; STK38L.
DR   PharmGKB; PA38252; -.
DR   eggNOG; prNOG08255; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG104247; -.
DR   InParanoid; Q9Y2H1; -.
DR   OMA; HIRERPP; -.
DR   OrthoDB; EOG9XWJHP; -.
DR   PhylomeDB; Q9Y2H1; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 43932; -.
DR   ArrayExpress; Q9Y2H1; -.
DR   Bgee; Q9Y2H1; -.
DR   CleanEx; HS_STK38L; -.
DR   Genevestigator; Q9Y2H1; -.
DR   GO; GO:0015629; C:actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0051128; P:regulation of cellular component organization; ISS:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; ATP-binding; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    464       Serine/threonine-protein kinase 38-like.
FT                                /FTId=PRO_0000086720.
FT   DOMAIN       90    383       Protein kinase.
FT   DOMAIN      384    453       AGC-kinase C-terminal.
FT   NP_BIND      96    104       ATP (By similarity).
FT   REGION       63     88       S100B binding (By similarity).
FT   ACT_SITE    213    213       Proton acceptor (By similarity).
FT   BINDING     119    119       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES      75     75       Phosphothreonine.
FT   MOD_RES     282    282       Phosphoserine; by autocatalysis.
FT   MOD_RES     442    442       Phosphothreonine.
FT   MOD_RES     450    450       Phosphothreonine (By similarity).
FT   VARIANT      99     99       G -> A (in a aLL TEL/AML1+ sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041199.
FT   MUTAGEN      75     75       T->A: Decreased kinase activity. Reduced
FT                                binding of S100B.
FT   MUTAGEN     119    119       K->A: Loss of autophosphorylation and
FT                                kinase activity.
FT   MUTAGEN     282    282       S->A: Loss of autophosphorylation and
FT                                kinase activity.
FT   MUTAGEN     442    442       T->A: Decreased kinase activity.
SQ   SEQUENCE   464 AA;  54003 MW;  71347E80BC3ADCB3 CRC64;
     MAMTAGTTTT FPMSNHTRER VTVAKLTLEN FYSNLILQHE ERETRQKKLE VAMEEEGLAD
     EEKKLRRSQH ARKETEFLRL KRTRLGLDDF ESLKVIGRGA FGEVRLVQKK DTGHIYAMKI
     LRKSDMLEKE QVAHIRAERD ILVEADGAWV VKMFYSFQDK RNLYLIMEFL PGGDMMTLLM
     KKDTLTEEET QFYISETVLA IDAIHQLGFI HRDIKPDNLL LDAKGHVKLS DFGLCTGLKK
     AHRTEFYRNL THNPPSDFSF QNMNSKRKAE TWKKNRRQLA YSTVGTPDYI APEVFMQTGY
     NKLCDWWSLG VIMYEMLIGY PPFCSETPQE TYRKVMNWKE TLVFPPEVPI SEKAKDLILR
     FCIDSENRIG NSGVEEIKGH PFFEGVDWEH IRERPAAIPI EIKSIDDTSN FDDFPESDIL
     QPVPNTTEPD YKSKDWVFLN YTYKRFEGLT QRGSIPTYMK AGKL
//
